211 related articles for article (PubMed ID: 36755856)
1. Real-world data to build explainable trustworthy artificial intelligence models for prediction of immunotherapy efficacy in NSCLC patients.
Prelaj A; Galli EG; Miskovic V; Pesenti M; Viscardi G; Pedica B; Mazzeo L; Bottiglieri A; Provenzano L; Spagnoletti A; Marinacci R; De Toma A; Proto C; Ferrara R; Brambilla M; Occhipinti M; Manglaviti S; Galli G; Signorelli D; Giani C; Beninato T; Pircher CC; Rametta A; Kosta S; Zanitti M; Di Mauro MR; Rinaldi A; Di Gregorio S; Antonia M; Garassino MC; de Braud FGM; Restelli M; Lo Russo G; Ganzinelli M; Trovò F; Pedrocchi ALG
Front Oncol; 2022; 12():1078822. PubMed ID: 36755856
[TBL] [Abstract][Full Text] [Related]
2. [Real-world study on the efficacy and prognostic predictive biomarker of patients with metastatic non-small cell lung cancer treated with programmed death-1/programmed death ligand 1 inhibitors].
Zhu WJ; Zhu HH; Liu YT; Lin L; Xing PY; Hao XZ; Cong MH; Wang HY; Wang Y; Li JL; Feng Y; Hu XS
Zhonghua Zhong Liu Za Zhi; 2022 May; 44(5):416-424. PubMed ID: 35615798
[No Abstract] [Full Text] [Related]
3. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013257. PubMed ID: 33316104
[TBL] [Abstract][Full Text] [Related]
4. Machine learning algorithm to predict response to immunotherapy in real-life settings for patients with advanced melanoma.
Frenard C; Blanchet K; Lecerf P; Varey E; Khammari A; Dréno B
Eur J Dermatol; 2023 Apr; 33(2):75-80. PubMed ID: 37431109
[TBL] [Abstract][Full Text] [Related]
5. Machine Learning for Prediction of Immunotherapy Efficacy in Non-Small Cell Lung Cancer from Simple Clinical and Biological Data.
Benzekry S; Grangeon M; Karlsen M; Alexa M; Bicalho-Frazeto I; Chaleat S; Tomasini P; Barbolosi D; Barlesi F; Greillier L
Cancers (Basel); 2021 Dec; 13(24):. PubMed ID: 34944830
[TBL] [Abstract][Full Text] [Related]
6. Single or combined immune checkpoint inhibitors compared to first-line platinum-based chemotherapy with or without bevacizumab for people with advanced non-small cell lung cancer.
Ferrara R; Imbimbo M; Malouf R; Paget-Bailly S; Calais F; Marchal C; Westeel V
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013257. PubMed ID: 33930176
[TBL] [Abstract][Full Text] [Related]
7. Explainable artificial intelligence model for identifying COVID-19 gene biomarkers.
Yagin FH; Cicek İB; Alkhateeb A; Yagin B; Colak C; Azzeh M; Akbulut S
Comput Biol Med; 2023 Mar; 154():106619. PubMed ID: 36738712
[TBL] [Abstract][Full Text] [Related]
8. Explainable machine learning models based on multimodal time-series data for the early detection of Parkinson's disease.
Junaid M; Ali S; Eid F; El-Sappagh S; Abuhmed T
Comput Methods Programs Biomed; 2023 Jun; 234():107495. PubMed ID: 37003039
[TBL] [Abstract][Full Text] [Related]
9. Prediction of Perforated and Nonperforated Acute Appendicitis Using Machine Learning-Based Explainable Artificial Intelligence.
Akbulut S; Yagin FH; Cicek IB; Koc C; Colak C; Yilmaz S
Diagnostics (Basel); 2023 Mar; 13(6):. PubMed ID: 36980481
[TBL] [Abstract][Full Text] [Related]
10. [Peripheral Blood Inflammation Indicators as Predictive Indicators in
Immunotherapy of Advanced Non-small Cell Lung Cancer].
Xia J; Chen Y; Wen S; Du X; Shen B
Zhongguo Fei Ai Za Zhi; 2021 Sep; 24(9):632-645. PubMed ID: 34521188
[TBL] [Abstract][Full Text] [Related]
11. First-line immunotherapy in non-small cell lung cancer patients with poor performance status: a systematic review and meta-analysis.
Facchinetti F; Di Maio M; Perrone F; Tiseo M
Transl Lung Cancer Res; 2021 Jun; 10(6):2917-2936. PubMed ID: 34295688
[TBL] [Abstract][Full Text] [Related]
12. Explainable Machine Learning Model to Prediction EGFR Mutation in Lung Cancer.
Yang R; Xiong X; Wang H; Li W
Front Oncol; 2022; 12():924144. PubMed ID: 35814445
[TBL] [Abstract][Full Text] [Related]
13. Explainable AI-based Alzheimer's prediction and management using multimodal data.
Jahan S; Abu Taher K; Kaiser MS; Mahmud M; Rahman MS; Hosen ASMS; Ra IH
PLoS One; 2023; 18(11):e0294253. PubMed ID: 37972072
[TBL] [Abstract][Full Text] [Related]
14. Real-world data analysis of immune checkpoint inhibitors in stage III-IV adenocarcinoma and squamous cell carcinoma.
Sun M; Ji H; Xu N; Jiang P; Qu T; Li Y
BMC Cancer; 2022 Jul; 22(1):762. PubMed ID: 35831785
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of Response to Immune Checkpoint Inhibitor Monotherapy or
Combination with Chemotherapy for Patients with Advanced Non-small Cell Lung Cancer and High PD-L1 Expression].
Li H; Qin N; Yu M; Ma L; Wu Y; Zhang H; Zhang X; Li X; Wang J
Zhongguo Fei Ai Za Zhi; 2021 Mar; 24(3):161-166. PubMed ID: 33819965
[TBL] [Abstract][Full Text] [Related]
16. Machine Learning Using Real-World and Translational Data to Improve Treatment Selection for NSCLC Patients Treated with Immunotherapy.
Prelaj A; Boeri M; Robuschi A; Ferrara R; Proto C; Lo Russo G; Galli G; De Toma A; Brambilla M; Occhipinti M; Manglaviti S; Beninato T; Bottiglieri A; Massa G; Zattarin E; Gallucci R; Galli EG; Ganzinelli M; Sozzi G; de Braud FGM; Garassino MC; Restelli M; Pedrocchi ALG; Trovo' F
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053597
[TBL] [Abstract][Full Text] [Related]
17. Association of the advanced lung cancer inflammation index (ALI) with immune checkpoint inhibitor efficacy in patients with advanced non-small-cell lung cancer.
Mountzios G; Samantas E; Senghas K; Zervas E; Krisam J; Samitas K; Bozorgmehr F; Kuon J; Agelaki S; Baka S; Athanasiadis I; Gaissmaier L; Elshiaty M; Daniello L; Christopoulou A; Pentheroudakis G; Lianos E; Linardou H; Kriegsmann K; Kosmidis P; El Shafie R; Kriegsmann M; Psyrri A; Andreadis C; Fountzilas E; Heussel CP; Herth FJ; Winter H; Emmanouilides C; Oikonomopoulos G; Meister M; Muley T; Bischoff H; Saridaki Z; Razis E; Perdikouri EI; Stenzinger A; Boukovinas I; Reck M; Syrigos K; Thomas M; Christopoulos P
ESMO Open; 2021 Oct; 6(5):100254. PubMed ID: 34481329
[TBL] [Abstract][Full Text] [Related]
18. Cancer Metastasis Prediction and Genomic Biomarker Identification through Machine Learning and eXplainable Artificial Intelligence in Breast Cancer Research.
Yagin B; Yagin FH; Colak C; Inceoglu F; Kadry S; Kim J
Diagnostics (Basel); 2023 Oct; 13(21):. PubMed ID: 37958210
[TBL] [Abstract][Full Text] [Related]
19. An explainable artificial intelligence framework for risk prediction of COPD in smokers.
Wang X; Qiao Y; Cui Y; Ren H; Zhao Y; Linghu L; Ren J; Zhao Z; Chen L; Qiu L
BMC Public Health; 2023 Nov; 23(1):2164. PubMed ID: 37932692
[TBL] [Abstract][Full Text] [Related]
20. An Explainable Artificial Intelligence Framework for the Deterioration Risk Prediction of Hepatitis Patients.
Peng J; Zou K; Zhou M; Teng Y; Zhu X; Zhang F; Xu J
J Med Syst; 2021 Apr; 45(5):61. PubMed ID: 33847850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
